During the past decade, Chi Poissy St Germain conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 1 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chi Poissy St Germain" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 13 trials, followed by "Poissy-Saint Germain Hospital" with 6 trials sponsored, "ANRS, Emerging Infectious Diseases" with 5 trials sponsored, "Centre Hospitalier Departemental Vendee" with 5 trials sponsored and "Nantes University Hospital" with 5 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chi Poissy St Germain" #1 collaborator was "University Hospital, Tours" with 5 trials as a collaborator, "Ministry of Health, France" with 4 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator and "Lymphoma Study Association" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "Chi Poissy St Germain" are "Multiple Sclerosis" (5 trials), "Covid19" (3 trials), "Pregnancy" (3 trials), "Ventilator-associated Pneumonia" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Chi Poissy St Germain" in a lesser frequency.

Most popular intervention types in "Chi Poissy St Germain" are "Drug" (22 trials), "Device" (18 trials), "Other" (18 trials), "Procedure" (13 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Endotracheal tubes allowing SSD" (3 trials), "Endotracheal tubes not allowing SSD" (3 trials), "ABVD regimen" (2 trials) and "BEACOPP regimen" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chi Poissy St Germain" are 48 trials for "All" genders, 30 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Chi Poissy St Germain". 1 are not yet recruiting, 17 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Chi Poissy St Germain, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Chi Poissy St Germain, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 22 trials that are defined as “Not Applicable".